Hematologic Malignancies: ASCO Meeting Highlights New Approaches To Treatment
Studies Test New Agents Offering Relief From Treatment-Related Side Effects
Oral UFT Equivalent To FULV In Stage II and III Colon Cancer
Adjuvant Chemo Improves Survival In Early Lung Cancer
Treat Cancer, But Protect Heart Anderson Cardiologists Warn
NCI-Approved Clinical Trials
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - The Galleri MCD vote: What FDA asked its advisors to ignore
- FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma









